COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy

Abstract

We present a case of a 61-year-old woman with an atypical non-arteritic anterior ischemic optic neuropathy (NA-AION) as a unique manifestation of COVID-19. Furthermore, the patient worsened after Pfizer-BioNTech COVID-19 vaccine administration. Our findings suggest that NA-AION could result from microangiopathic/thrombotic events that may occur during SARS-CoV-2 infection and/or vaccination against COVID-19. This report sheds light on possible ophthalmologic complications of COVID-19.

Keywords

‌SARS-CoV-2 optic nerve‌vaccine‌optical coherence tomography angiography‌

Get full access to this article

View all access options for this article.

References

Hayreh

. Ischemic optic neuropathy. Prog Retin Eye Res 2009; 28: 34–62. 2008/12/10. DOI: 10.1016/j.preteyeres.2008.11.002.

Rho

Dryden

McGuffey

, et al. A Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19. Cureus 2020; 12: e11950. 2021/01/12. DOI: 10.7759/cureus.11950.

Moschetta

Fasolino

Kuijpers

. Non-arteritic anterior ischaemic optic neuropathy sequential to SARS-CoV-2 virus pneumonia: preventable by endothelial protection? BMJ case reports 2021; 14: e240542. DOI: 10.1136/bcr-2020-240542.

Savastano

Crincoli

Savastano

, et al. Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J Clin Med 2020; 9. 2020/09/12. DOI: 10.3390/jcm9092895.

Cines

Bussel

. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. The New England journal of medicine 2021; 384: 2254–2256. 2021/04/16. DOI: 10.1056/NEJMe2106315.